When Do Bilirubin Levels Rise Again After Phototherapy Ends?

Quick take: After phototherapy is stopped, most newborns see a modest rise in bilirubin within the first 12‑24 hours—often noticeable when the lights go off at night. The rebound is usually small, peaks around 24 hours, and then falls as the liver matures and feeding improves. If the level climbs sharply or the baby shows signs of jaundice, call your pediatrician.

It’s 2 a.m. and you’ve been watching your newborn’s little yellow‑tinted skin glow in the dim nursery light. You remember the nurse’s words about “phototherapy” and wonder why the jaundice seems to creep back when the room finally goes dark. You’re not alone—many parents notice a nighttime dip in bilirubin after the bright lights are turned off, and the uncertainty can feel overwhelming.

First, breathe. In most cases the rise is a normal part of the baby’s transition from hospital phototherapy to home care. The key is to understand what’s happening, how to keep an eye on it, and when a higher level truly needs a doctor’s attention. Below we’ll walk through how phototherapy works, the typical timeline for bilirubin rebound, the factors that can make the night‑time spike bigger, and practical steps you can take to stay ahead of the curve.

We’ll also give you a clear plan for home monitoring, share a simple calculator you can use to gauge your baby’s rebound risk, and answer the most common questions parents ask after the lights go out. By the end of this guide you’ll feel equipped to manage the “after‑phototherapy” period with confidence.

How phototherapy lowers bilirubin and why the lights matter

Phototherapy is essentially a light‑based “detox” for newborns with jaundice. Bilirubin is a yellow‑orange pigment created when red blood cells break down. In the first weeks of life, a baby’s liver—still learning its job—can’t process bilirubin quickly enough, so it builds up in the blood and deposits in the skin, giving that characteristic yellow hue.

When a newborn lies under a special blue‑green light, the energy from the light changes bilirubin’s structure in a process called photo‑isomerization. The altered molecules become water‑soluble and can be excreted in urine and stool without needing the liver’s full processing power. In other words, the light acts as a shortcut that lets the body dump excess bilirubin faster. This process specifically targets unconjugated bilirubin, which is the type that builds up in the blood to cause visible jaundice and is potentially harmful at very high levels.

Because the light must reach the skin directly, the infant is usually positioned with as much surface area exposed as possible—often with a blanket or diaper removed, and sometimes with a special fiber‑optic blanket that wraps around the baby. The more skin exposed, the more bilirubin can be “photoconverted.” The therapy is typically given continuously, 24 hours a day, until the bilirubin level falls below a treatment threshold set by guidelines such as the American Academy of Pediatrics (AAP) or the UK’s NICE. The effectiveness of phototherapy depends on several factors, including the intensity of the light, the specific wavelength (blue-green light is most effective), and the amount of skin surface area exposed to the light. These factors are carefully managed in a hospital setting to ensure maximum benefit for your baby.

When the lights are switched off, the shortcut disappears. The baby’s own liver has to pick up the full workload again, and any lingering bilirubin that wasn’t fully cleared can start to accumulate. This is why a night‑time rise is often observed once the phototherapy unit is dimmed or turned off for sleep. The liver's ability to process bilirubin relies on an enzyme called UDP-glucuronosyltransferase (UGT), which is often immature in newborns. As the liver matures and UGT activity increases, the body becomes more efficient at conjugating (making water-soluble) and excreting bilirubin naturally.

Typical timeline for bilirubin to rise after the lights are turned off

Most

• 0–6 hours after lights off: Bilirubin may stay steady or rise slightly (often <0.5 mg/dL). This early window is usually quiet because the body is still processing the light‑converted bilirubin that was already in the system.
• 6–12 hours: A gradual upward trend becomes noticeable, especially if the baby is sleeping through the night and feeding less frequently. This is when the liver begins to take over more of the processing.
• 12–24 hours: This is the typical “rebound peak.” Levels often increase by 1–2 mg/dL from the lowest post‑phototherapy reading. For most term infants, this rise stays well below the treatment threshold, meaning it’s usually not high enough to require restarting phototherapy.
• 24–48 hours: Bilirubin generally plateaus or starts to fall as feeding becomes more regular and the liver gains functional capacity. The body is adapting to the absence of the external light therapy.

In preterm infants or babies with additional risk factors (e.g., breastfeeding difficulties, hemolysis, or genetic conditions), the rebound can be larger and may extend beyond 48 hours. That’s why follow‑up labs are recommended for higher‑risk newborns. The extent of the rebound also depends on how high the bilirubin was before treatment, the duration of phototherapy, and the baby's overall health. A higher initial bilirubin level or shorter duration of phototherapy may sometimes lead to a more noticeable rebound.

Below is a simplified comparison of typical rebound patterns based on gestational age and feeding method:

These numbers are averages from AAP and NICE recommendations and should be used as a guide rather than a hard rule. Your baby’s individual curve may differ, especially if they have underlying conditions that affect bilirubin metabolism. It's important to remember that these are average increases and your baby's healthcare provider will interpret their specific bilirubin levels in the context of their age, risk factors, and overall health status.

Factors that influence nighttime bilirubin rebound

While the basic physics of phototherapy set the stage, several baby‑specific and environmental factors determine how high the rebound climbs and how quickly it settles.

Feeding frequency and adequacy

Every feeding helps move bilirubin through the gut. Breast milk contains a hormone called prolactin that promotes gut motility, while formula provides a more consistent caloric load. Babies who feed less often—common during night‑time sleep cycles—may experience slower bilirubin clearance, leading to a larger rebound. Ensuring at least 8–12 feeds per 24 hours (roughly every 2–3 hours) can blunt the night‑time rise. Frequent feeding not only aids in bilirubin excretion through stool but also helps establish a healthy gut microbiome, which further supports bilirubin metabolism and reduces its reabsorption into the bloodstream, a process known as enterohepatic circulation.

Hydration status

Dehydration reduces stool volume, which is the main route for bilirubin excretion after phototherapy. Signs of inadequate hydration include fewer wet diapers (less than six in 24 hours after the first day) and concentrated urine. Proper hydration supports the gut’s “washing out” of bilirubin. When a baby is well-hydrated, they produce more urine and stool, which are the primary ways the body eliminates bilirubin that has been processed by the liver or altered by phototherapy. Dehydration can slow this process significantly, contributing to a higher rebound.

Liver maturity

In term infants, the liver typically reaches functional maturity by 2–3 weeks of age, but preterm babies may take longer. Immature liver enzymes (e.g., UDP‑glucuronosyltransferase, or UGT) limit bilirubin conjugation, making the rebound more pronounced. Serial bilirubin checks are especially important for these infants. The UGT enzyme is crucial for converting unconjugated bilirubin (which is fat-soluble and can cross the blood-brain barrier) into conjugated bilirubin (which is water-soluble and can be safely excreted). When this enzyme is not fully active, the body struggles to clear bilirubin efficiently, leading to higher levels and a greater rebound potential.

Breast‑milk jaundice vs. physiological jaundice

Breast‑milk jaundice—a separate condition that appears after the first week—can cause bilirubin to rise steadily despite adequate feeding. It’s thought to stem from substances in breast milk that inhibit bilirubin conjugation. If the rise continues beyond 48 hours after phototherapy, discuss breast‑milk jaundice with your pediatrician. This is distinct from "breastfeeding jaundice," which is typically seen in the first few days of life and is related to insufficient milk intake, leading to dehydration and reduced bilirubin excretion. Breast-milk jaundice, by contrast, is a benign condition that can persist for several weeks or even months but rarely reaches dangerous levels.

Hemolysis or blood‑type incompatibility

Conditions that increase red‑cell breakdown, such as ABO or Rh incompatibility, flood the system with bilirubin faster than the liver can handle it. In these cases, the rebound can be sharp and may require additional phototherapy or exchange transfusion. When red blood cells break down too rapidly (hemolysis), they release a large amount of heme, which is then converted into bilirubin. This sudden overload can overwhelm even a relatively mature liver, making it difficult to clear the bilirubin effectively, and thus leading to a more significant and potentially dangerous rebound.

Room lighting and sleep environment

While regular household lighting is far weaker than phototherapy, very dim environments can reduce the residual “ambient” bilirubin conversion that might occur with a night‑light. Some parents keep a low‑intensity blue‑green night‑light on for a few hours after discharge; evidence on its effectiveness is limited, but it’s unlikely to cause harm. The primary benefit of keeping a room well-lit (with natural or artificial light) during the day is to allow for better visual assessment of your baby's skin color, making it easier to spot any worsening jaundice. However, it's important to balance this with creating a calm, sleep-conducive environment for your baby at night.

Understanding different types of jaundice

Jaundice in newborns isn't a single condition, but rather a symptom that can arise from several underlying causes. Knowing the difference can help you understand your baby's specific situation and the implications of bilirubin rebound.

Physiological Jaundice

This is the most common type, affecting about 60% of full-term newborns and 80% of preterm babies. It typically appears 2-4 days after birth and resolves within two weeks. Physiological jaundice occurs because a newborn's liver is still developing and isn't yet efficient at processing bilirubin. The levels usually peak within the first week and then gradually decline. The rebound after phototherapy for physiological jaundice is generally well-managed by frequent feeding and liver maturation.

Breastfeeding Jaundice

Also known as "lack of breast milk jaundice," this type occurs in the first week of life, particularly in breastfed babies who aren't getting enough milk. Insufficient milk intake leads to dehydration and less frequent stools, which means less bilirubin is excreted. This type is often resolved by increasing feeding frequency and ensuring good latch and milk transfer. The rebound risk is higher if feeding issues persist post-phototherapy.

Breast Milk Jaundice

This is a less common type that appears after the first week of life and can persist for several weeks or even months. It's thought to be caused by substances in breast milk that interfere with the baby's liver processing bilirubin. Despite ongoing jaundice, babies with breast milk jaundice are usually healthy, feeding well, and gaining weight. While it can cause elevated bilirubin, it rarely reaches dangerous levels and typically doesn't require stopping breastfeeding. Rebound after phototherapy for this type might be more prolonged, but usually not severe.

Pathological Jaundice

This type of jaundice is more serious and requires immediate medical attention. It appears within the first 24 hours of life, or bilirubin levels rise very rapidly, or reach extremely high levels. Causes include blood group incompatibilities (like Rh or ABO incompatibility), infections, genetic conditions, or liver diseases. Babies with pathological jaundice are at higher risk for severe hyperbilirubinemia and a more significant, potentially dangerous rebound after phototherapy. These cases often require more intensive monitoring and follow-up.

What signs to watch for during the rebound period

Most newborns with a mild rebound will look the same as before—quiet, sleepy, and with only a faint yellow tint. However, a few warning signs merit closer attention:

• Increasing yellow color: If the skin (especially the face and chest) becomes noticeably more orange or the sclera (white of the eye) turns yellow, note the change. To check for jaundice visually, gently press a finger on your baby's skin (forehead or nose) and then lift it. If the skin looks yellow when you release pressure, it's a sign of jaundice. This is best done in natural daylight.
• Decreased feeding: Fewer than 8 feeds in 24 hours or a sudden drop in appetite. A jaundiced baby might be too sleepy to feed effectively, creating a cycle where less feeding leads to higher bilirubin.
• Fewer wet diapers: Less than six wet diapers after the first 24 hours can suggest dehydration. Adequate hydration is crucial for bilirubin excretion, so a decrease in wet diapers is a red flag.
• Lethargy or poor responsiveness: A baby who is unusually sleepy, hard to arouse, or not smiling when engaged. Extreme lethargy can be a sign that bilirubin levels are reaching dangerous levels and potentially affecting the brain.
• Vomiting or stool changes: Persistent vomiting or very dark, tar‑colored stools may indicate bilirubin is not moving through the gut efficiently or that there's another underlying issue. Very pale or chalky stools can also be a sign of liver issues.
• High-pitched crying or arching: These can be signs of neurological irritation due to very high bilirubin levels (kernicterus), which is a medical emergency.

Any of these signs, especially when combined with a known rise in bilirubin, should prompt a call to your pediatrician. In most cases the doctor will want a repeat bilirubin measurement within 12–24 hours to confirm the trend. Trust your instincts as a parent; if something feels off, it's always best to get it checked.

Potential risks of untreated high bilirubin

While a mild bilirubin rebound is common and usually harmless, it's important to understand why doctors monitor bilirubin levels so carefully and why phototherapy is used. The primary concern with very high, untreated unconjugated bilirubin is the risk of it crossing the blood-brain barrier and causing neurological damage.

Acute Bilirubin Encephalopathy (ABE)

When unconjugated bilirubin levels become excessively high, it can be toxic to the brain. This can lead to a condition called acute bilirubin encephalopathy. Symptoms can include extreme lethargy, poor feeding, decreased muscle tone (hypotonia), and high-pitched crying. If left untreated, it can progress to arching of the back and neck, seizures, and even coma. Early recognition and treatment are critical to prevent further damage.

Kernicterus

Kernicterus is the chronic and permanent neurological damage that results from acute bilirubin encephalopathy. It is a rare but devastating condition. Children affected by kernicterus may develop athetoid cerebral palsy (a type of cerebral palsy characterized by involuntary movements), hearing loss, visual problems, dental enamel dysplasia, and intellectual disabilities. This is why healthcare providers are so diligent in monitoring and treating significant jaundice, especially in the first few days and weeks of life. The goal of phototherapy and careful monitoring of rebound is to prevent bilirubin levels from ever reaching the threshold where kernicterus becomes a risk.

The good news is that with modern medical care and parental vigilance, kernicterus is largely preventable. By understanding the signs of worsening jaundice and knowing when to seek medical help, you play a crucial role in safeguarding your baby's health. The AAP and NICE guidelines provide clear thresholds for intervention, ensuring that babies receive timely and effective treatment to prevent these serious complications.

Monitoring bilirubin at home and after discharge

After the hospital discharge, parents become the primary observers of bilirubin trends. While most families rely on visual cues, several objective tools can help track the baby’s progress.

Bilirubinometer (transcutaneous device)

Many pediatric offices provide a handheld transcutaneous bilirubinometer that measures skin reflectance. Some parents can borrow or purchase a home model, though accuracy varies. If you have access, taking a reading once per day—preferably in the morning before the first feed—can give you a concrete number to discuss with your provider. While convenient, home transcutaneous bilirubinometers should be used as a screening tool, not a definitive diagnostic one. A high reading on a home device should always be confirmed with a serum bilirubin blood test, which is more accurate. Always follow your pediatrician’s advice regarding their use.

Follow‑up labs

Standard practice is a repeat serum bilirubin test 24–48 hours after phototherapy ends, especially for babies who were close to treatment thresholds or have specific risk factors. The lab result gives a precise level and helps the pediatrician decide whether continued observation or another phototherapy session is needed. These blood tests are crucial because they measure the exact amount of bilirubin in the bloodstream, providing the most accurate picture of your baby's levels and guiding clinical decisions based on established guidelines for age and risk factors. Your doctor will weigh this result against your baby's age in hours and other clinical factors.

Keeping a feeding and diaper log

Write down the time of each feeding, the type (breast, formula, mixed), and the number of wet and dirty diapers. This log not only reassures you that the baby is staying hydrated, but also provides clear data for the doctor if bilirubin rises unexpectedly. This simple tool is incredibly powerful. It helps you ensure your baby is getting adequate nutrition and hydration, which are key to clearing bilirubin. It also provides objective evidence for your healthcare provider, allowing them to assess your baby's intake and output without relying solely on memory.

Use the Phototherapy Rebound Risk calculator

To get a personalized sense of how likely a rebound is for your baby, you can try the Phototherapy Rebound Risk tool. Input your infant’s gestational age, birth weight, and the highest bilirubin level treated, and the calculator will estimate the probability of a significant rebound, helping you gauge how closely to monitor. This calculator is a helpful educational resource but is not a substitute for medical advice or professional assessment. It can empower you with information to discuss with your pediatrician, helping you ask informed questions about your baby's specific risk.

Practical steps to minimize bilirubin spikes after phototherapy

Even though a mild rebound is normal, you can take proactive measures to keep bilirubin from climbing too high.

1. Prioritize frequent feeds: Aim for at least every 2–3 hours, including night feeds. If you’re breastfeeding, consider a lactation consultant to ensure the baby is latching well and emptying the breast. For sleepy babies, try unwrapping them, changing their diaper, or gently rubbing their feet to rouse them for feeds. Adequate milk intake is paramount for bilirubin excretion.
2. Encourage hydration: Offer a small amount of expressed breast milk or formula if the baby seems reluctant to feed, especially before sleep. Ensure baby is actively swallowing during feeds, not just suckling. If you are concerned about dehydration, discuss with your pediatrician or a lactation consultant.
3. Keep skin exposed: Dress the baby in lightweight, breathable clothing (e.g., onesies with short sleeves) to maximize surface area for any ambient light to aid bilirubin conversion. While not as powerful as phototherapy, natural daylight can offer some minor benefit. Ensure baby isn't getting cold if lightly dressed.
4. Maintain a regular sleep‑wake schedule: Try to wake the baby gently for feeds during the night rather than letting them sleep for long uninterrupted stretches. This ensures consistent intake and helps prevent bilirubin from building up during extended sleep.
5. Monitor temperature: Over‑heating can increase bilirubin production. Keep the room between 68–72 °F (20–22 °C) and avoid heavy blankets. Overheating can also make babies more lethargic, reducing their willingness to feed.
6. Track diaper output: Six or more wet diapers per day is a good sign of adequate fluid intake. Dark stools may indicate bilirubin is staying in the gut; discuss with your doctor. The color and consistency of stools (yellow and seedy for breastfed, softer for formula-fed) are good indicators of gut health and bilirubin excretion.
7. Stay in touch with your pediatrician: Share your feeding log and any visual changes promptly. Early communication can prevent unnecessary readmission. Don't hesitate to call if you have any concerns, even if they seem minor.

These practices are endorsed by the AAP’s clinical guidelines on newborn jaundice, which emphasize feeding adequacy as the most effective way to reduce bilirubin levels after phototherapy. Your active participation in these steps can make a significant difference in your baby's recovery and well-being.

When re-admission for phototherapy might be necessary

While most bilirubin rebounds are mild and resolve on their own, there are specific situations where your baby might need to return to the hospital for more phototherapy. This decision is always made by a pediatrician based on a combination of factors, including your baby's age in hours, their current bilirubin level, and any underlying risk factors. It's not a reflection on your parenting, but a necessary medical intervention to protect your baby's health.

Bilirubin Levels Exceeding Treatment Thresholds

The primary reason for re-admission is if your baby's bilirubin level rises above the specific treatment threshold for their age (in hours) and risk category. These thresholds are defined by guidelines from organizations like the American Academy of Pediatrics (AAP) and the National Institute for Health and Care Excellence (NICE). Your pediatrician will use charts that factor in gestational age, risk factors (like prematurity, ABO incompatibility, or G6PD deficiency), and the bilirubin level to determine if intervention is needed.

Rapidly Rising Bilirubin

Even if the absolute bilirubin level isn't yet at the highest threshold, a very rapid increase in bilirubin (e.g., more than 0.2 mg/dL per hour) can be a cause for concern. A rapid rise suggests that the body is producing bilirubin faster than it can be cleared, and proactive treatment might be needed to prevent it from reaching dangerous levels.

Clinical Signs of Worsening Jaundice

If your baby exhibits severe symptoms of jaundice, such as extreme lethargy, difficulty feeding, high-pitched crying, arching of the back, or signs of acute bilirubin encephalopathy, they will likely be re-admitted for immediate and intensive phototherapy, and potentially other treatments. These symptoms indicate that bilirubin may be affecting the brain, and swift action is crucial.

Inadequate Response to Home Management

If, despite frequent feeding and close monitoring at home, your baby's jaundice is clearly worsening visually, and a follow-up blood test confirms a concerning rise, re-admission may be discussed. Sometimes, the initial phototherapy may have been stopped too soon, or there's an underlying factor that wasn't fully resolved. Your medical team will guide you on the best course of action.

Remember, re-admission is a protective measure to ensure your baby's long-term health. If your doctor recommends it, they have your baby's best interest at heart. It's a temporary step to get those bilirubin levels back into a safe range.

From our medical team: A modest rise in bilirubin after the lights are turned off is typical, but it’s the pattern—not a single reading—that matters. Keep a close eye on feeding, diaper output, and any change in skin color. If you notice a rapid increase or any concerning symptoms, a quick blood test can reassure you and your baby’s doctor that everything is on track. Always communicate openly with your healthcare provider about any worries you have.

Myth vs. fact

Myth: The baby’s jaundice will always get worse at night after phototherapy.

Fact: Most infants experience only a small, temporary rise that peaks within 12–24 hours and then declines as feeding improves and the liver matures.

Myth: You must keep the hospital phototherapy lights on at home to prevent rebound.

Fact: Home phototherapy is rarely needed; ensuring frequent feeds and hydration is far more effective for most babies. Hospital-grade phototherapy devices are much more powerful than anything you'd use at home.

Myth: A yellow tint after discharge means the baby needs another round of phototherapy.

Fact: A mild yellow color is common and often harmless. Only a bilirubin level that exceeds the treatment threshold or rapid worsening warrants repeat phototherapy. Visual jaundice can persist for some time even after levels are safe.

Myth: Exposing your baby to direct sunlight can treat jaundice at home.

Fact: While sunlight does contain blue-green light, it's not a controlled or safe method for treating jaundice. It's impossible to regulate the dose, and there's a significant risk of sunburn or overheating for a newborn. Medical phototherapy units are specifically designed for safe and effective treatment.

Key takeaways

• Biliru­bin rebound after lights off usually peaks 12–24 hours post‑phototherapy and stays modest.
• Frequent feeding (8–12 times/24 h) and adequate hydration are the most powerful tools to keep bilirubin low.
• Track wet diapers, skin color, and feeding patterns; call your pediatrician if you see rapid worsening.
• Use a transcutaneous bilirubinometer or schedule a follow‑up blood test for precise numbers.
• The Phototherapy Rebound Risk calculator can help you estimate your baby’s specific rebound probability.
• Untreated high bilirubin can lead to serious neurological complications like kernicterus, making careful monitoring essential.

Frequently asked questions

Why does bilirubin rise again after the lights are turned off?

The rise occurs because the phototherapy light, which temporarily converts bilirubin into a water‑soluble form, is no longer present, so the baby’s immature liver must process the remaining bilirubin on its own. The body's natural bilirubin production continues, and without the phototherapy shortcut, the liver needs time to catch up.

How soon after phototherapy can bilirubin levels increase again?

Levels can start to climb within the first 6 hours, with the typical peak occurring between 12 and 24 hours after the lights are switched off. This is why follow-up bilirubin checks are often scheduled around this time.

Is a nighttime bilirubin spike normal for newborns?

Yes, a modest nighttime increase is common, especially in the first 48 hours after phototherapy, as long as the baby continues to feed well and the skin color does not become markedly more yellow. It's a natural part of the body adjusting to the absence of external light therapy.

What signs indicate a bilirubin rebound after lights off?

Watch for a growing yellow hue on the face or chest, fewer than six wet diapers in 24 hours, reduced feeding frequency, lethargy, or vomiting. Any of these combined with a known bilirubin rise should prompt a call to your pediatrician, as they could signal a significant rebound.

Should I be concerned if my baby’s bilirubin rises at night?

Only if the increase is rapid, the level exceeds the treatment threshold for their age and risk factors, or the baby shows concerning symptoms like extreme lethargy or poor feeding. A gradual rise within the expected range is usually harmless and resolves as the baby's liver matures.

How can I prevent bilirubin from rising after phototherapy ends?

Ensure frequent feeds (every 2–3 hours), keep the baby well‑hydrated, monitor diaper output, expose as much skin as comfortably possible to ambient light, and maintain a regular sleep‑wake schedule that includes night‑time feeds. These measures support the body's natural bilirubin clearance.

How long does jaundice typically last in newborns?

For most full-term newborns with physiological jaundice, it usually resolves within two weeks. In breastfed babies, mild jaundice can sometimes last for 2-3 months (breast milk jaundice), but as long as the baby is healthy and gaining weight, it's typically not a concern. Your pediatrician will monitor and advise if it persists longer.

What is the difference between physiological and pathological jaundice?

Physiological jaundice is common, appears after 24 hours of life, and is usually mild, resolving on its own. Pathological jaundice is more serious, appears within the first 24 hours, or involves very high or rapidly rising bilirubin levels, often due to underlying medical conditions like blood group incompatibility.

When to call your doctor

If you notice any of the following, contact your pediatrician right away:

• Skin or eye color becomes noticeably more yellow (especially on the face, chest, or sclera).
• Feeding drops below 8 feeds/24 h or the baby seems unusually sleepy, hard to wake, or limp.
• Fewer than six wet diapers in a full day, or very dark, concentrated urine.
• Persistent vomiting, severe constipation, or very pale/chalky stools.
• Any sudden change in behavior, such as difficulty waking, limpness, high‑pitched crying, or arching of the back and neck.
• You simply have a strong feeling that something is not right with your baby.

These symptoms could signal a bilirubin level that’s climbing beyond safe limits and may require repeat phototherapy or, in rare cases, an exchange transfusion. This article is for informational purposes only and does not replace personalized medical advice.

References

1. American Academy of Pediatrics. “Management of Hyperbilirubinemia in the Newborn Infant 35 or Greater Weeks of Gestation.” 2022 Policy Statement.
2. National Institute for Health and Care Excellence (NICE). “Jaundice in newborns: diagnosis and management.” NG15, 2021.
3. World Health Organization. “Guidelines on the prevention and treatment of neonatal jaundice.” 2020.
4. American College of Obstetricians and Gynecologists (ACOG). “Neonatal Jaundice.” Practice Bulletin No. 220, 2022.
5. Centers for Disease Control and Prevention (CDC). “Neonatal Jaundice – Causes and Prevention.” Updated 2023.
6. British Paediatric Association. “Guidelines for the care of newborns with jaundice.” 2021.
7. National Health Service (NHS). “Jaundice in newborn babies.” 2022.
8. International Liaison Committee on Resuscitation (ILCOR). “Neonatal Resuscitation and Early Care.” 2023.
9. Harvard Health Publishing. “Newborn Jaundice: What Parents Need to Know.” 2022.
10. European Society for Paediatric Research. “Bilirubin metabolism in early life.” Review article, 2021.
11. Maisels, M. J. (2015). "Jaundice in the Newborn: A Guide for Clinicians." Wolters Kluwer.
12. Bhutani, V. K., & Johnson, L. H. (2011). "Kernicterus: A Global Perspective on a Preventable Problem." Seminars in Perinatology, 35(3), 118-121.